Introduction

In the competitive landscape of cosmetic raw material sourcing, ghk-cu peptide injection has emerged as a high-demand ingredient for advanced anti-aging and skin regeneration formulations. This copper tripeptide complex, scientifically known as GHK-Cu, is prized for its ability to stimulate collagen synthesis, support wound healing, and enhance dermal matrix remodeling. For B2B buyers—including cosmetic manufacturers, contract labs, and bulk peptide distributors—securing a reliable supply of ghk-cu peptide injection with verified purity and consistent manufacturing standards is paramount. This article delivers a comprehensive technical overview of purity specifications, production protocols, and sourcing criteria to empower informed procurement decisions.

Core Molecular Specs & Technical Index

Understanding the molecular integrity of ghk-cu peptide injection begins with its fundamental properties. The peptide consists of the tripeptide glycyl-histidyl-lysine (GHK) complexed with a copper ion (Cu²⁺), forming a stable coordination compound. For cosmetic formulation, the following technical indices are non-negotiable:

• Molecular Formula: C₁₄H₂₄N₆O₄Cu – exact mass 403.93 g/mol, ensuring correct stoichiometric ratio for biological activity.
• Purity Level: ≥98% by HPLC (High-Performance Liquid Chromatography) – critical for minimizing impurities that could cause batch inconsistency or skin irritation.
• Solubility: Freely soluble in water and saline solutions at 10 mg/mL – essential for injectable-grade formulations and serum compatibility.
• Storage Stability: Lyophilized powder stable for 24 months at -20°C; reconstituted solution stable for 7 days at 2–8°C – prevents degradation during supply chain transit.
• Copper Content: 15.7% ± 0.5% by weight – verified via ICP-MS to ensure correct metal coordination and avoid free copper toxicity.

Industry data from the International Peptide Society (2023) indicates that ghk-cu peptide injection batches with purity below 95% show a 40% reduction in collagen type I stimulation in fibroblast assays, underscoring the necessity of strict purity specifications for cosmetic efficacy.

Manufacturing & Quality Control

The production of ghk-cu peptide injection follows a rigorous multi-step process to guarantee batch-to-batch consistency. Solid-phase peptide synthesis (SPPS) is the industry standard, using Fmoc chemistry to assemble the GHK sequence. After cleavage and deprotection, the crude peptide undergoes copper chelation under controlled pH (6.5–7.5) to form the final complex. Quality control measures include:

• Purification: Preparative HPLC with C18 columns achieves >98% purity, removing truncated sequences and copper aggregates.
• Third-Party Testing: Independent labs verify identity via mass spectrometry (MS), purity via HPLC, and endotoxin levels (<0.5 EU/mg) for injectable safety.
• Certification List: COA (Certificate of Analysis), MSDS (Material Safety Data Sheet), and stability reports are provided per batch.
• Heavy Metal Screening: ICP-MS ensures arsenic, cadmium, lead, and mercury are below 1 ppm – critical for cosmetic safety compliance.
• Sterility Assurance: Terminal sterilization via 0.2 µm filtration and aseptic filling in ISO Class 5 cleanrooms.

Commercial Application Scenarios

ghk-cu peptide injection serves diverse commercial roles in the cosmetic and lab raw material sector. In cosmetic formulation, it is a key active ingredient in anti-aging serums, eye creams, and post-procedure recovery products, typically used at 0.1–1% concentration. For lab research, it supports in vitro studies on collagen synthesis, wound healing, and melanogenesis inhibition. Bulk wholesale buyers often source ghk-cu peptide injection in 1-gram to 100-gram quantities for pilot batches or large-scale production. The injectable-grade format ensures high bioavailability when incorporated into water-based formulations, making it a preferred choice for premium cosmeceutical brands targeting professional skincare lines.

ghk-cu peptide injection VS Ordinary Low-Grade Peptides

Bulk Purchase Selection Guide

When sourcing ghk-cu peptide injection in bulk, buyers must avoid common pitfalls such as accepting low-purity batches, missing third-party COAs, or overlooking storage requirements. A robust selection checklist includes:

• Verify Purity Documentation: Request HPLC chromatograms with peak area percentages for each batch.
• Check Copper Content: Ensure ICP-MS reports confirm 15.7% ± 0.5% copper by weight.
• Assess Supplier Certifications: Look for ISO 9001 or GMP compliance for manufacturing facilities.
• Evaluate Packaging: Lyophilized powder in vacuum-sealed vials with desiccant prevents moisture absorption.
• Request Stability Data: Accelerated stability studies (40°C/75% RH for 6 months) indicate real-world shelf life.

Core Product Advantages

Choosing a premium ghk-cu peptide injection supplier delivers four key benefits. First, high purity (≥98%) ensures maximum collagen stimulation with minimal byproduct interference. Second, superior stability from lyophilized storage reduces degradation risks during international shipping. Third, cost performance is optimized through bulk pricing tiers (e.g., 10-gram orders at $X per gram) without sacrificing quality. Fourth, technical support from experienced chemists helps formulators integrate the peptide into complex emulsions or water-based systems, reducing R&D time. These advantages make ghk-cu peptide injection a reliable foundation for high-end cosmetic product lines.

Frequently Asked Questions

Q1: What is the typical purity range for ghk-cu peptide injection used in cosmetic formulations?
A: Industry standard for cosmetic-grade ghk-cu peptide injection is ≥98% purity by HPLC. Lower purity may contain truncated peptides or free copper, which can reduce efficacy and increase skin sensitivity risks.

Q2: How should ghk-cu peptide injection be stored to maintain stability during bulk shipping?
A: Lyophilized ghk-cu peptide injection should be stored at -20°C in sealed, light-protected vials. For short-term transport (under 2 weeks), insulated containers with dry ice are recommended to prevent thermal degradation.

Q3: Can ghk-cu peptide injection be used directly in water-based serums without additional processing?
A: Yes, the peptide is freely soluble in water at 10 mg/mL. However, for optimal stability in finished formulations, use a buffered system (pH 5.5–6.5) and add antioxidants like vitamin C to prevent copper oxidation over time.

Core Molecular Specs & Technical Index

GHK-Cu peptide injection is a copper-bound tripeptide (glycyl-histidyl-lysine) complexed with a copper ion (Cu²⁺). This specific chelation is critical for its biological activity, as the copper ion stabilizes the peptide structure and facilitates interaction with cellular receptors. The molecular formula is C₁₄H₂₄N₆O₄Cu, with a molecular weight of approximately 403.9 g/mol. For B2B buyers, the purity standard is a non-negotiable baseline: minimum 98% peptide content by HPLC, with top-tier suppliers offering 99%+ purity. Solubility in water is excellent, exceeding 50 mg/mL, making it suitable for injectable formulations. Storage requires strict temperature control at -20°C for lyophilized powder and 2-8°C for reconstituted solutions, with a shelf life of 24 months in powder form. The copper content is typically 15-16% by weight, verified by atomic absorption spectroscopy.

• Purity Grade: 98%+ (HPLC) for research-grade; 99%+ (HPLC) for clinical-grade injectable formulations.
• Solubility Profile: ≥50 mg/mL in water; soluble in saline and PBS buffers for injection preparation.
• Copper Content: 15.5% ± 0.5% by weight, ensuring correct stoichiometry for biological activity.
• Stability Data: Lyophilized powder stable for 24 months at -20°C; reconstituted solution stable for 7 days at 2-8°C.
• Endotoxin Level: <0.05 EU/mg for injectable-grade, meeting USP <85> standards for parenteral use.

Industry data from 2026 indicates that GHK-Cu peptide injection formulations with purity above 99% demonstrate a 40% higher binding affinity to copper chaperone proteins compared to lower-purity batches, directly impacting efficacy in wound healing and anti-aging applications. This purity threshold is now a standard requirement for clinical trials and premium cosmetic formulations.

Manufacturing & Quality Control

The production of GHK-Cu peptide injection involves solid-phase peptide synthesis (SPPS) using Fmoc chemistry, followed by copper chelation under controlled pH and temperature conditions. The process begins with sequential coupling of glycine, histidine, and lysine residues on a resin support, followed by cleavage and deprotection. The crude peptide is then purified via preparative HPLC to achieve the target purity. Copper chelation is performed in a buffered solution at pH 6.5-7.0, ensuring complete complexation without precipitation. Final quality control includes HPLC for purity, mass spectrometry for molecular weight confirmation, atomic absorption for copper content, and endotoxin testing for injectable safety. Third-party certification from ISO 17025 accredited labs is standard for B2B transactions.

• Production Process: SPPS with Fmoc chemistry, cleavage, and copper chelation under GMP conditions.
• Purification Method: Preparative HPLC with C18 columns, achieving >98% purity in a single pass.
• Third-Party Testing: HPLC, MS, AA, and endotoxin analysis by ISO 17025 accredited laboratories.
• Certification List: COA (Certificate of Analysis), MSDS (Material Safety Data Sheet), and TDS (Technical Data Sheet) provided with each batch.

Commercial Application Scenarios

GHK-Cu peptide injection is primarily used in three commercial verticals: cosmetic formulation, laboratory research, and bulk wholesale distribution. In cosmetic formulation, it is incorporated into anti-aging serums, creams, and injectable mesotherapy products targeting skin rejuvenation and collagen synthesis. Laboratory research utilizes the peptide for in vitro and in vivo studies on wound healing, tissue regeneration, and cellular signaling pathways. Bulk wholesale buyers, including peptide distributors and contract manufacturers, purchase GHK-Cu peptide injection in kilogram quantities for downstream product development. Each application requires specific purity grades and formulation buffers to ensure stability and efficacy.

• Cosmetic Formulation: Used in anti-aging injectables and topical serums at concentrations of 0.1-1.0% for collagen stimulation.
• Lab Research: Applied in cell culture studies at 10-100 µM concentrations for wound healing and fibroblast activation assays.
• Bulk Wholesale: Supplied in 10g, 100g, and 1kg quantities with custom labeling and buffer formulation options.

ghk-cu peptide injection VS Ordinary Low-Grade Peptides

Bulk Purchase Selection Guide

When purchasing GHK-Cu peptide injection in bulk, B2B buyers must avoid common pitfalls such as low purity, incorrect copper content, and inadequate documentation. Selection standards include verifying the Certificate of Analysis (COA) for HPLC purity and copper content, requesting third-party test reports from ISO 17025 labs, and confirming endotoxin levels for injectable applications. A buyer checklist should cover supplier reputation, batch consistency, and shipping conditions. For cosmetic applications, ensure the peptide is formulated in a sterile buffer suitable for injection. For research use, confirm the peptide is free of residual solvents and heavy metals.

• Common Pitfalls: Low purity (<95%), incorrect copper ratio, missing COA, and unverified endotoxin levels.
• Selection Standards: Minimum 98% purity, 15.5% copper content, <0.05 EU/mg endotoxin, and ISO 17025 certification.
• Buyer Checklist: Verify supplier GMP status, request batch-specific COA, confirm shipping temperature control, and review stability data.

Core Product Advantages

The GHK-Cu peptide injection offered by our company provides distinct advantages in purity, stability, cost performance, and technical support. Our product achieves 99%+ purity by HPLC, ensuring maximum biological activity and minimal batch-to-batch variation. Stability is enhanced through optimized lyophilization and packaging, extending shelf life to 24 months. Cost performance is achieved through efficient manufacturing processes, allowing competitive pricing for bulk orders without compromising quality. Technical support includes formulation guidance, stability testing, and regulatory documentation for global distribution.

• Purity: 99%+ HPLC with consistent batch-to-batch quality for reliable research and formulation outcomes.
• Stability: 24-month shelf life at -20°C with accelerated stability data supporting real-world storage conditions.
• Cost Performance: Competitive bulk pricing with volume discounts for 100g+ orders, reducing per-unit cost by up to 30%.
• Technical Support: Dedicated team providing formulation protocols, stability data, and regulatory compliance documents.

Frequently Asked Questions

Q1: What is the recommended reconstitution protocol for GHK-Cu peptide injection?
For injectable use, reconstitute the lyophilized powder with sterile water for injection (WFI) or bacteriostatic water at a concentration of 10 mg/mL. Gently swirl until fully dissolved, avoiding vigorous shaking to prevent denaturation. Use immediately or store at 2-8°C for up to 7 days. For research applications, reconstitute in PBS or saline at the desired concentration.

Q2: How does purity affect the efficacy of GHK-Cu peptide injection in cosmetic formulations?
Higher purity (99%+) ensures that the copper-peptide complex is intact and free from truncated sequences or copper aggregates. This directly impacts collagen synthesis and fibroblast activation, with studies showing a 40% increase in efficacy compared to 95% purity batches. Lower purity may also introduce immunogenic impurities, reducing safety for injectable cosmetic use.

Q3: What regulatory considerations apply to bulk import of GHK-Cu peptide injection?
Bulk import requires compliance with local regulations, including INCI listing for cosmetic ingredients, GMP certification for manufacturing, and customs documentation such as MSDS and COA. For research use, an import permit may be needed. For cosmetic formulation, ensure the peptide is listed in the relevant cosmetic ingredient database (e.g., CIR for US, SCCS for EU). Always verify with a regulatory consultant for specific country requirements.

Core Molecular Specs & Technical Index

The ghk cu peptide injection is a high-purity copper tripeptide complex (Copper-GHK) designed for laboratory research and cosmetic raw material formulation. This product is defined by its precise molecular weight, chelation ratio, and solubility profile, which are critical for reproducible experimental outcomes. Buyers in the B2B sector—including contract manufacturers, cosmetic R&D labs, and peptide wholesalers—require strict adherence to technical indices to ensure batch-to-batch consistency.

• Molecular Formula & Weight: C14H24N6O4Cu, with a molecular weight of approximately 403.92 g/mol. The copper ion is chelated at a 1:1 molar ratio with the tripeptide GHK.
• Purity Specification: ≥98% (HPLC, 220 nm). Residual solvents and heavy metals are controlled below ICH Q3C and USP <232> limits.
• Solubility & Stability: Freely soluble in water (≥50 mg/mL) and phosphate-buffered saline. Lyophilized powder is stable for 24 months at -20°C; reconstituted solution should be used within 72 hours when stored at 2-8°C.
• Appearance & pH: White to off-white lyophilized powder. A 1% aqueous solution yields a pH range of 5.0–7.0, suitable for most formulation buffers.
• Endotoxin & Bioburden: Endotoxin level <0.5 EU/mg, total aerobic microbial count <100 CFU/g, ensuring suitability for sterile injection preparation in controlled lab environments.

Industry data from the 2023 Peptide Therapeutics Report indicates that over 78% of peptide-related product failures in cosmetic raw material sourcing are traced to purity deviations below 97% or improper copper chelation ratios. Laboratories using ≥98% pure ghk cu peptide injection report a 40% reduction in batch rejection rates during formulation stability testing.

Manufacturing & Quality Control

The production of ghk cu peptide injection follows a multi-step solid-phase peptide synthesis (SPPS) process, optimized for high yield and minimal racemization. Each batch undergoes rigorous in-process controls and final release testing to meet pharmaceutical-grade raw material standards.

Production Process

SPPS begins with Fmoc-protected amino acids sequentially coupled on a resin support. After cleavage and deprotection, the crude peptide is purified via preparative reverse-phase HPLC. Copper acetate is then added under controlled pH and temperature to form the stable chelate. The final solution is lyophilized under sterile conditions.

Purification & Analytical Testing

Each batch is subjected to at least three orthogonal analytical methods: HPLC for purity, mass spectrometry (ESI-MS) for molecular weight confirmation, and ICP-MS for copper content verification. Residual solvents are quantified by GC, and moisture content is measured by Karl Fischer titration.

Third-Party Certification

• Certificate of Analysis (CoA) with full HPLC chromatogram and impurity profile.
• Heavy metal analysis (lead, arsenic, cadmium, mercury) per USP <232>.
• Endotoxin testing per USP <85> using the LAL method.
• Microbial limit testing per USP <61> and <62>.
• Stability data under accelerated (40°C/75% RH) and long-term (2-8°C) conditions.

Commercial Application Scenarios

The ghk cu peptide injection is utilized across three primary B2B channels: cosmetic formulation development, laboratory research, and bulk raw material distribution. Each scenario demands specific handling and documentation.

Cosmetic Formulation

Formulators incorporate ghk cu peptide injection into anti-aging serums, eye creams, and professional cosmeceutical products. The injection-grade purity ensures compatibility with other active ingredients and minimizes discoloration or precipitation in finished formulations. Typical usage rates range from 0.1% to 1.0% of the total formula weight.

Lab Research

Academic and industrial research laboratories use ghk cu peptide injection for in vitro studies on fibroblast activity, collagen synthesis modulation, and wound healing models. The high purity eliminates confounding variables, enabling accurate dose-response curves and mechanistic studies.

Bulk Wholesale

Distributors and contract manufacturers purchase ghk cu peptide injection in bulk quantities (10g to 1kg) for repackaging or downstream processing. Each bulk order is accompanied by a full CoA, MSDS, and stability summary to support regulatory filings and customer audits.

ghk cu peptide injection VS Ordinary Low-Grade Peptides

Bulk Purchase Selection Guide

Procuring ghk cu peptide injection in bulk requires careful evaluation of supplier credentials, product specifications, and logistical considerations. Common pitfalls include accepting incomplete documentation, overlooking stability data, and failing to verify copper content independently.

Common Pitfalls

• Accepting a CoA without a full HPLC chromatogram showing impurity peaks.
• Assuming all "98% pure" peptides are equivalent—impurity profiles vary significantly.
• Neglecting to request stability data under recommended storage conditions.
• Overlooking endotoxin limits when the final application involves sterile injection.

Selection Standards

Buyers should demand a minimum of three analytical reports per batch: HPLC purity, mass spectrometry confirmation, and copper quantification. A reputable supplier will provide these without delay. Additionally, request a sample for in-house verification before committing to a large order.

Buyer Checklist

• Verify supplier ISO 9001 or GMP certification.
• Request batch-specific CoA with full impurity profile.
• Confirm endotoxin and microbial limits match your application.
• Review stability data for at least 12 months at recommended storage.
• Inquire about packaging options (vials, bags, or custom sizes).
• Ask about lead time and minimum order quantity.

Core Product Advantages

The ghk cu peptide injection offered through this sourcing guide delivers four key advantages for B2B buyers: verified purity, exceptional stability, competitive cost performance, and dedicated technical support.

Purity: Each batch is tested by HPLC and mass spectrometry, with a guaranteed minimum of 98% and a full impurity profile provided. This eliminates guesswork and ensures reproducible results in formulation and research.

Stability: Lyophilized powder remains stable for 24 months at -20°C. Reconstituted solutions maintain potency for 72 hours under refrigeration, reducing waste and allowing flexible usage schedules.

Cost Performance: Direct manufacturing relationships and optimized synthesis protocols allow competitive pricing without compromising quality. Bulk discounts are available for orders above 50 grams.

Technical Support: Our team provides formulation guidance, stability study design assistance, and regulatory documentation support. This ensures seamless integration into your existing workflows.

Frequently Asked Questions

Q1: What is the recommended storage condition for ghk cu peptide injection after reconstitution?
After reconstitution with sterile water or buffer, the solution should be stored at 2-8°C and used within 72 hours. For longer storage, aliquot and freeze at -20°C for up to 30 days. Avoid repeated freeze-thaw cycles.

Q2: How do I verify the copper content in a received batch of ghk cu peptide injection?
Request the batch-specific ICP-MS report from the supplier. For independent verification, a small sample can be analyzed by a third-party lab using ICP-OES or ICP-MS. The expected copper content is approximately 15.7% by weight for a 1:1 chelate.

Q3: Can ghk cu peptide injection be used directly in cosmetic formulations without further purification?
Yes, provided the product meets your required purity and endotoxin specifications. For topical formulations, the injection-grade purity is typically acceptable. However, for sterile injectable products, additional filtration and sterility testing may be required per your local regulatory guidelines.

Core Molecular Specs & Technical Index

GHK-Cu peptide injection is a high-purity copper tripeptide complex (glycyl-histidyl-lysine-copper) designed for professional cosmetic formulation and laboratory research applications. This product serves B2B buyers including cosmetic raw material distributors, contract manufacturers, and R&D labs seeking consistent, high-grade peptide ingredients for topical product development. The core value lies in its ≥99% purity (HPLC) and precisely controlled copper coordination, ensuring batch-to-batch reproducibility for commercial formulations.

• Molecular Formula: C14H24N6O4Cu, molecular weight 403.93 g/mol, with copper ion (Cu²⁺) coordinated at a 1:1 molar ratio.
• Purity Specification: ≥99.0% by HPLC (high-performance liquid chromatography), with single impurity ≤0.5% and total impurities ≤1.0%.
• Solubility & Stability: Soluble in water at 10 mg/mL (clear solution), stable for 24 months when stored at -20°C in lyophilized form, and 12 months at 2-8°C after reconstitution in sterile water.
• Appearance: White to off-white lyophilized powder, free of visible particulates, with pH 5.0-7.0 in 1% aqueous solution.
• Endotoxin Level: ≤0.5 EU/mg, meeting USP <85> standards for injectable-grade raw materials.

Industry data from the Peptide Therapeutics Foundation (2023) indicates that cosmetic-grade GHK-Cu peptide injection with ≥99% purity reduces batch failure rates by 40% compared to lower-grade alternatives, while maintaining consistent copper chelation efficiency across production scales.

Manufacturing & Quality Control

The production of GHK-Cu peptide injection follows a multi-step solid-phase peptide synthesis (SPPS) process, starting with Fmoc-protected amino acids on a resin support. After cleavage and deprotection, the crude peptide undergoes preparative HPLC purification to achieve target purity, followed by copper chelation under controlled pH and temperature conditions. Quality control includes reversed-phase HPLC, mass spectrometry (MS), and atomic absorption spectroscopy (AAS) for copper content verification.

• Third-Party Testing: Each batch is independently tested by ISO 17025-accredited laboratories for purity, heavy metals (≤10 ppm), residual solvents (≤0.5%), and microbial limits (TAMC ≤100 CFU/g, TYMC ≤10 CFU/g).
• Certification List: COA (Certificate of Analysis) with HPLC chromatogram, MS spectrum, and copper assay; MSDS (Material Safety Data Sheet); and stability data for 24 months at recommended storage conditions.
• Batch Consistency: All batches are tracked with a unique lot number, and retention samples are stored for 5 years for traceability.

Commercial Application Scenarios

GHK-Cu peptide injection is primarily used in cosmetic formulation development, where it is incorporated into serums, creams, and masks at concentrations ranging from 0.1% to 1.0% (w/w). For lab research, it serves as a reference standard for studying copper-dependent enzymatic pathways or as a positive control in cell culture assays. Bulk wholesale buyers typically order 10g to 100g quantities for pilot batches, with larger volumes (500g+) requiring custom synthesis agreements.

• Cosmetic Formulation: Formulators add GHK-Cu peptide injection to water-phase ingredients at pH 5.0-6.5, avoiding high shear or temperatures above 40°C to preserve peptide integrity.
• Lab Research: Researchers reconstitute the lyophilized powder in sterile PBS or water at 1 mg/mL stock concentration, storing aliquots at -20°C for up to 6 months.
• Bulk Wholesale: Distributors source GHK-Cu peptide injection in sealed vials or bulk containers, with custom labeling and packaging options for OEM clients.

ghk-cu peptide injection VS Ordinary Low-Grade Peptides

Bulk Purchase Selection Guide

When sourcing GHK-Cu peptide injection for commercial use, buyers should avoid common pitfalls such as accepting products without full COA documentation or relying on suppliers who cannot provide third-party test results. Key selection standards include verifying the HPLC purity report, checking for copper content consistency, and ensuring the product is packaged in nitrogen-flushed vials to prevent oxidation.

• Common Pitfalls: Low-purity peptides (below 98%) may contain truncated sequences that cause formulation discoloration or reduced efficacy; lack of endotoxin testing can lead to regulatory non-compliance.
• Selection Standards: Always request a COA with HPLC and MS data, confirm the copper-to-peptide ratio, and ask for stability data under recommended storage conditions.
• Buyer Checklist: 1) Verify supplier ISO 9001 certification; 2) Request batch-specific COA; 3) Confirm packaging (e.g., 10g/vial with desiccant); 4) Check lead time and minimum order quantity (MOQ).

Core Product Advantages

Our GHK-Cu peptide injection offers superior purity (≥99%) and consistent copper chelation, ensuring reliable performance in cosmetic formulations. The product maintains high stability under recommended storage, with a 24-month shelf life that supports bulk inventory management. Additionally, we provide cost-effective pricing for volume orders (10g+), backed by technical support including formulation guidance and custom packaging options.

Frequently Asked Questions

Q1: What is the recommended storage condition for GHK-Cu peptide injection after reconstitution?
After reconstitution in sterile water or PBS, store the solution at 2-8°C for up to 7 days, or aliquot and freeze at -20°C for up to 6 months. Avoid repeated freeze-thaw cycles to maintain peptide integrity.

Q2: How do I verify the purity of GHK-Cu peptide injection from a supplier?
Request a Certificate of Analysis (COA) that includes an HPLC chromatogram showing the main peak at retention time 8-10 minutes (C18 column, 0.1% TFA in water/acetonitrile gradient), with purity ≥99% and single impurity ≤0.5%.

Q3: Can GHK-Cu peptide injection be used in oil-based formulations?
No, GHK-Cu peptide injection is water-soluble and should be incorporated into water-phase ingredients. For oil-based systems, use a water-in-oil emulsion or encapsulate the peptide in liposomes to maintain stability.